Standout Papers
Citation Impact
Citing Papers
Patterns of Cancer Incidence, Mortality, and Prevalence Across Five Continents: Defining Priorities to Reduce Cancer Disparities in Different Geographic Regions of the World
2006 Standout
Circulating Breast Tumor Cells Exhibit Dynamic Changes in Epithelial and Mesenchymal Composition
2013 StandoutScience
2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines
2016 Standout
Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet
2009 Standout
Acute Myeloid Leukemia or Myelodysplastic Syndrome in Randomized Controlled Clinical Trials of Cancer Chemotherapy With Granulocyte Colony-Stimulating Factor: A Systematic Review
2010
Metastasis: from dissemination to organ-specific colonization
2009 Standout
Fulvestrant plus palbociclib versus fulvestrant plus placebo for treatment of hormone-receptor-positive, HER2-negative metastatic breast cancer that progressed on previous endocrine therapy (PALOMA-3): final analysis of the multicentre, double-blind, phase 3 randomised controlled trial
2016 Standout
Trastuzumab containing regimens for early breast cancer
2012
Breast cancer
2019 Standout
Adjuvant radiation therapy of regional lymph nodes in breast cancer - a meta-analysis of randomized trials- an update
2015
Macrophages orchestrate breast cancer early dissemination and metastasis
2017
Multiple Roles of Cyclin-Dependent Kinase 4/6 Inhibitors in Cancer Therapy
2012
American Society of Clinical Oncology 2007 Update of Recommendations for the Use of Tumor Markers in Breast Cancer
2007 Standout
Triple-Negative Breast Cancer
2010 Standout
The association of chemotherapy versus hormonal therapy and health outcomes among patients with hormone receptor-positive, HER2−negative metastatic breast cancer: experience from the patient perspective
2014
The cyclin-dependent kinase 4/6 inhibitor palbociclib in combination with letrozole versus letrozole alone as first-line treatment of oestrogen receptor-positive, HER2-negative, advanced breast cancer (PALOMA-1/TRIO-18): a randomised phase 2 study
2014 Standout
Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective, multicentre cohort study
2013 Standout
A comparative analysis of radiotherapy use and patient outcome in males and females with breast cancer
2005
Locoregional Recurrence After Sentinel Lymph Node Dissection With or Without Axillary Dissection in Patients With Sentinel Lymph Node Metastases
2010 Standout
The mechanisms of Hedgehog signalling and its roles in development and disease
2013 Standout
Estrogen Receptors: How Do They Signal and What Are Their Targets
2007 Standout
Disseminated tumor cells in the bone marrow of patients with ductal carcinoma in situ
2011
Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits
2009 Standout
Genes that mediate breast cancer metastasis to the brain
2009 StandoutNature
Breast cancer
2016 Standout
Omitting radiation therapy after lumpectomy for pure DCIS does not reduce the risk of salvage mastectomy
2017
Breast-Conserving Surgery With or Without Radiotherapy in Older Breast Patients With Early Stage Breast Cancer: A Systematic Review and Meta-analysis
2013
Carcinoma of the breast in males
1998
Cell cycle proteins as promising targets in cancer therapy
2017 Standout
Epithelial-Mesenchymal Transitions in Development and Disease
2009 Standout
EMT and Dissemination Precede Pancreatic Tumor Formation
2012 Standout
Racial/ethnic differences in survival rates in a population‐based series of men with breast carcinoma†
2002
Stages at presentation, prognostic factors, and outcome of breast cancer in males
1999
Randomized Multicenter Trial of Sentinel Node Biopsy Versus Standard Axillary Treatment in Operable Breast Cancer: The ALMANAC Trial
2006 Standout
Taxanes in the treatment of breast cancer: Have we better defined their role in older patients? A position paper from a SIOG Task Force
2015
N-myc alters the fate of preneoplastic cells in a mouse model of medulloblastoma
2009
Tumor Metastasis: Molecular Insights and Evolving Paradigms
2011 Standout
Breast cancer precursors revisited: molecular features and progression pathways
2010
Histopathological findings and follow-up after prophylactic mastectomy and immediate breast reconstruction in 100 women from families with hereditary breast cancer
2008
Hereditary ovarian carcinoma: Heterogeneity, molecular genetics, pathology, and management
2009
Longitudinal risk-based health care for adult survivors of childhood cancer
2003
Sentinel lymph node biopsy in male breast cancer patients
2004
An update on male breast cancer and future directions for research and treatment
2013
Anastrozole versus tamoxifen for the prevention of locoregional and contralateral breast cancer in postmenopausal women with locally excised ductal carcinoma in situ (IBIS-II DCIS): a double-blind, randomised controlled trial
2015
Survivors of childhood and adolescent cancer: life-long risks and responsibilities
2013 Standout
Breast carcinoma in men
2004 Standout
Cancer of the male breast
2000
Relationship Between Clinical and Pathologic Features of Ductal Carcinoma In Situ and Patient Age
2009
Clinical relevance of biologic factors in male breast cancer
2001
Molecular markers in male breast carcinoma
1998
Male breast carcinoma
1999
Variations in compliance to quality indicators by age for 41,871 breast cancer patients across Europe: A European Society of Breast Cancer Specialists database analysis
2015
Acute leukemia as a secondary malignancy in children and adolescents: Current findings and issues
2008
Adjuvant therapy with tamoxifen compared to aromatase inhibitors for 257 male breast cancer patients
2012
Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2010 Standout
Chronic Health Conditions in Adult Survivors of Childhood Cancer
2006 Standout
Effect of tamoxifen and radiotherapy in women with locally excised ductal carcinoma in situ: long-term results from the UK/ANZ DCIS trial
2010
Association Between CHEK2*1100delC and Breast Cancer: A Systematic Review and Meta-Analysis
2018
Male breast cancer
2006 Standout
Toremifene: An evaluation of its safety profile
2005
Synchronous bilateral noninvasive ductal carcinoma of the male breast: A case report
2003
Mitigation of hematologic radiation toxicity in mice through pharmacological quiescence induced by CDK4/6 inhibition
2010
Emerging Biological Principles of Metastasis
2017 Standout
Understanding and management of male breast cancer: a critical review
2007
Adjuvant pegylated liposomal doxorubicin for older women with endocrine nonresponsive breast cancer who are NOT suitable for a “standard chemotherapy regimen”: The CASA randomized trial
2013
The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth
2023 Standout
EMT: 2016
2016 Standout
Clinical Effect of Point Mutations in Myelodysplastic Syndromes
2011 Standout
Male breast cancer: is the scenario changing
2008
Axillary Dissection vs No Axillary Dissection in Women With Invasive Breast Cancer and Sentinel Node Metastasis
2011 Standout
Male breast cancer: a disease distinct from female breast cancer
2018
A review of estrogen receptor/androgen receptor genomics in male breast cancer
2017
Long-term Complications Following Childhood and Adolescent Cancer: Foundations for Providing Risk-based Health Care for Survivors
2004
Microenvironmental regulation of metastasis
2008 Standout
Therapy-Related Myeloid Leukemia
2008
Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2019 Standout
The Epidemiology of Myelodysplastic Syndromes
2010
Cisplatin in cancer therapy: Molecular mechanisms of action
2014 Standout
Systemic Spread Is an Early Step in Breast Cancer
2008
Ductal carcinoma in situ (DCIS) in the male breast
1998
Value of Information Analysis of Multiparameter Tests for Chemotherapy in Early Breast Cancer: The OPTIMA Prelim Trial
2017
Male breast cancer
2009
Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2015
Breast-conserving surgery with or without irradiation in women aged 65 years or older with early breast cancer (PRIME II): a randomised controlled trial
2015
The history and future of targeting cyclin-dependent kinases in cancer therapy
2015 Standout
19. MALE BREAST CANCER: AETIOLOGY, GENETICS AND CLINICAL MANAGEMENT
2002
Systematic Review: Surveillance for Breast Cancer in Women Treated With Chest Radiation for Childhood, Adolescent, or Young Adult Cancer
2010
An analysis of male and female breast cancer treatment and survival among demographically identical pairs of patients
1999
American Society of Clinical Oncology Guideline Recommendations for Sentinel Lymph Node Biopsy in Early-Stage Breast Cancer
2005 Standout
PIK3CA mutations are frequently observed in BRCAX but not BRCA2-associated male breast cancer
2013
External Beam Radiotherapy in the Treatment of Male Breast Carcinoma: Patterns of Failure in a Single Institute Experience
2005
Breast Cancer Treatment
2019 Standout
High frequency of germ-line BRCA2 mutations among Hungarian male breast cancer patients without family history.
1999
Prognostic Variables in Male Breast Cancer
2000
Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America
2016 Standout
Tamoxifen for Prevention of Breast Cancer
2003
Male Breast Cancer: A Population-Based Comparison With Female Breast Cancer
2009 Standout
Epithelial Plasticity: A Common Theme in Embryonic and Cancer Cells
2013 StandoutScience
Post-mastectomy radiation in male breast cancer
2002
The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia
2016 Standout
Effect of Short-Term Hormone Replacement Therapy on Breast Cancer Risk Reduction After Bilateral Prophylactic Oophorectomy in BRCA1 and BRCA2 Mutation Carriers: The PROSE Study Group
2005 Standout
Inherited mutations in cancer susceptibility genes are common among survivors of breast cancer who develop therapy‐related leukemia
2015
Predictors of local recurrence after treatment of ductal carcinoma in situ
1999
Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer
2018 Standout
Breast Cancer in Men
2002 Standout
BRCA2 mutations and androgen receptor expression as independent predictors of outcome of male breast cancer patients.
2003
Works of B. Cutuli being referenced
Concurrent trastuzumab with adjuvant radiotherapy in HER2-positive breast cancer patients: acute toxicity analyses from the French multicentric study
2008
Ductal carcinoma in situ of the breast results of conservative and radical treatments in 716 patients
2001
Breast-conserving therapy for ductal carcinoma in situ of the breast: the French Cancer Centers’ experience
2002
Breast cancer occurred after treatment for Hodgkin's disease: analysis of 133 cases
2001
Heterogeneity of ductal carcinoma in situ and its effects on management
2006
EUSOMA position regarding breast implant associated anaplastic large cell lymphoma (BIA-ALCL) and the use of textured implants
2019
Management of elderly patients with breast cancer: updated recommendations of the International Society of Geriatric Oncology (SIOG) and European Society of Breast Cancer Specialists (EUSOMA)
2012
Male breast cancer: Results of the treatments and prognostic factors in 397 cases
1995
Male breast cancer. Evolution of treatment and prognostic factors. Analysis of 489 cases
2009
Local recurrence after ductal carcinoma in situ breast conserving treatment. Analysis of 195 cases
2013
Adjuvant radiotherapy in the management of axillary node negative invasive breast cancer: A qualitative systematic review
2012
Radical surgery and conservative treatment of ductal carcinoma in situ of the breast
1992
Iatrogenic risks of endometrial carcinoma after treatment for breast cancer in a large French case-control study
1998
Ductal carcinoma in situ of the male breast. Analysis of 31 cases
1997
Current management of DCIS: a review
2007
Anthracyclines, Mitoxantrone, Radiotherapy, and Granulocyte Colony-Stimulating Factor: Risk Factors for Leukemia and Myelodysplastic Syndrome After Breast Cancer
2006
The management of lobular carcinoma in situ (LCIS). Is LCIS the same as ductal carcinoma in situ (DCIS)?
2006
Strategies in treating male breast cancer
2007
Multidisciplinary Meeting on Male Breast Cancer: Summary and Research Recommendations
2010 Standout